Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Thomas Haberberger"'
Autor:
Martin Kolb, Jennifer Robertson, Margaret M. Kelly, Peter J. Margetts, Jack Gauldie, Philippe Bonniaud, Thomas Haberberger
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 168:770-778
Connective tissue growth factor (CTGF) is felt to be one of the key profibrotic factors and is a downstream effector molecule mediating the action of transforming growth factor (TGF)-beta1, a cytokine known to induce severe and progressive fibrosis.
Autor:
Carol M. Black, Giorgia Martini, David Abraham, George R. Martin, Thomas Haberberger, Xu Shiwen, Richard Stratton, Alan M. Holmes, Andrew Leask
Publikováno v:
Journal of Clinical Investigation. 108:241-250
Patients with scleroderma receiving Iloprost as a treatment for severe Raynaud's phenomenon report a reduction in skin tightness, suggesting that this drug inhibits skin fibrosis. Connective tissue growth factor (CTGF), a recently described profibrot
Autor:
Hans Bender, Thomas Haberberger, Hans J. Biersack, F. F. Russ Knapp, Masako Hosono, Stefan Guhlke, Paul O. Zamora, Makoto Hosono
Publikováno v:
Annals of Nuclear Medicine. 12:83-88
In order to evaluate the feasibility of 188Re-labeled antibodies for radioimmunotargeting, monoclonal antibody B72.3, recognizing TAG-72, expressed on the surface membranes of colorectal cancer cells, was directly labeled with 188Re, obtained from a
Autor:
Thomas Haberberger, Makoto Hosono, Paul O. Zamora, Hans Bender, Hans-Jürgen Biersack, Masako Hosono, Stefan Guhlke, Furn F. Knapp
Publikováno v:
Japanese Journal of Cancer Research : Gann
We examined the potential of radiolabeled somatostatin analogs, 125I-Tyr-3-octreotide (125I-octreotide), (111)In-DTPA(diethylenetriaminepentaacetatic acid)-D-Phe-1-octreotide (111In-octreotide), and 188Re-octreotide for targeting small-cell lung canc
Autor:
Thomas Haberberger, Michael Kneba, Sock-Cheng Lewin-Koh, Doris Kim, Elizabeth Punnoose, Jacques J.M. van Dongen, Yuda Zhu, Anton W. Langerak, Matthias Ritgen, Henrik Knecht, Coen Bernaards, Jill Ray, Anke Schilhabel
Publikováno v:
Blood. 126:2924-2924
Introduction. Minimal residual disease (MRD) is an objective measure of disease status defined by the number of leukemic cells in the blood or bone marrow of leukemic patients. In recent clinical studies of chronic lymphocytic leukemia (CLL), undetec
Publikováno v:
SAE Technical Paper Series.
Publikováno v:
SAE Technical Paper Series.
Autor:
Thomas Haberberger, David C. Gervasi, Mircea Ivan, Ronald C. Conaway, William G. Kaelin, Kristen S. Michelson, Keiichi Kondo, Joan W. Conaway, Haifeng Yang, Volkmar Günzler, Irina Sorokina
The product of the von Hippel–Lindau gene, pVHL, targets the α subunits of the heterodimeric transcription factor hypoxia-inducible factor (HIF) for polyubiquitination in the presence of oxygen. The binding of pVHL to HIF is governed by the enzyma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe66189e7305441c90271c35a90ab5ed
https://europepmc.org/articles/PMC129695/
https://europepmc.org/articles/PMC129695/
Publikováno v:
Cell and tissue research. 300(1)
In mouse hepatocytes, the gap junctional proteins connexin32 (Cx32) and connexin26 (Cx26) are expressed in the same gap junctional plaque. Expression of the major Cx32 protein is downregulated during liver regeneration and cholestasis. Here we have a